DSRU Scientific Publications
Use our keyword search facility to match our publications with your area of interest.
253 publications found, showing 81 to 100
-
A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England
Wilton LV, Shakir SA,
Drug Saf. January 2002 -
Prescription-Event Monitoring
Shakir S,
Pharmacovigilance. January 2002 -
Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill Criteria
Shakir SAW, Layton D,
Drug Saf. January 2002 -
Drug safety: Foreword
Shakir S,
Drug Saf. January 2002 -
Matched controls in a case-control study. Does matching by doctor's list mean matching by relative deprivation?
Thorogood M, Arscott A, Walls P, Dunn NR, Mann R,
Int J Social Research Methodol. January 2002 -
Prescription-event monitoring and reporting of adverse drug reactions
Heeley E, Riley J, Layton D, Wilton LV, Shakir SA,
Lancet. December 2001 -
Montelukast and improvement of eczema: observations from a prescription event monitoring study in England
Biswas P, Wilton LV, Shakir SA,
Int J Clin Pharmacol Ther. December 2001 -
The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England
Biswasl PN, Wilton LV, Pearcel GL, Freemantle S, Shakir SA,
J Psychopharmacol. December 2001 -
Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports
Clark D, Layton D, Shakir SA,
BMJ. September 2001 -
Monitoring the safety of over the counter drugs
Clark D, Layton D, Shakir SAW,
BMJ. September 2001 -
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997
Craig-McFeely PM, Acharya NV, Shakir SAW,
Eur J Clin Pharmacol. July 2001 -
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine
Wilton LV, Heeley EL, Pickering RM, Shakir SA,
J Psychopharmacol. June 2001 -
Finasteride and tamsulosin used in benign prostatic hypertrophy: A review of the prescription-event monitoring data
Shakir S, Pearce G, Mann RD,
BJU International. June 2001 -
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England
Layton D, Clark DW, Pearce GL, Shakir SA,
Eur J Clin Pharmacol. May 2001 -
Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England
Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E,
BMJ. March 2001 -
Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group
Emerson A, Martin RM, Tomlin M, Mann RD,
Pharmacoepidemiol Drug Saf. March 2001 -
Cardiovascular events in users of sildenafil [9] (multiple letters)
Dunn N, Boshier A, Layton D, Wilton LV, Heeley E, Shakir SAW,
BMJ. March 2001 -
Cardiovascular events in users of sildenafil: Results from first phase of prescription event monitoring in England
Shakir SAW, Wilton LV, Boshier A, Layton D, Heeley E,
BMJ. March 2001 -
The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: Results from the MICA case-control study
Dunn NR, Arscott A, Thorogood M,
Contraception. February 2001 -
Myocardial infarction and oral contraceptives
Arscott A, Nettelfield P,
Prof Nurse (London, England). February 2001